Author:
Ilani Tal,Reznik Nava,Yeshaya Noa,Feldman Tal,Vilela Patrick,Lansky Zipora,Javitt Gabriel,Shemesh Michal,Brenner Ori,Elkis Yoav,Varsano Neta,Murray Nathan,Azadi Parastoo,Jaramillo Ana M.,Evans Christopher M.,Fass Deborah
Abstract
AbstractMucus shields the intestinal epithelium from pathogens and provides a supportive environment for commensal bacteria. Mucus is composed of enormous, heavily glycosylated proteins called mucins, which become disulfide crosslinked in a multi-step biosynthetic pathway culminating in the Golgi apparatus and secretory granules of goblet cells. We observed that knockout mice lacking the Golgi-localized disulfide catalyst QSOX1 produced poorly protective colon mucus, were hypersensitive to induced colitis, and had an altered microbiome. The initial hypothesis arising from these observations was that QSOX1 catalyzes disulfide crosslinking of mucins. Contrary to this hypothesis, the disulfide-mediated polymerization of mucins and related glycoproteins proceeded normally without QSOX1. Instead, we found that QSOX1 forms regulatory disulfides in Golgi glycosyltransferases and thereby promotes effective sialylation of the colon glycome. Our findings reveal that enzymatic control of Golgi redox state impacts glycan elaboration in goblet cells, and that this pathway is crucial for maintaining mucosal function.
Publisher
Cold Spring Harbor Laboratory